17β-Estradiol transcriptionally represses human insulin receptor gene expression causing cellular insulin resistance

Leukemia Research

Volumn 29, Issue 1, 2005, Pages 79-87

  García Arencibia, Moisés ^a   Molero, Susana ^a   Dávila, Norma ^b   Carmen Carranza, M ^a   Calle, Consuelo ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

17 estradiol; 17 Estradiol; E2; ER; ER ; ER ; ERE; estrogen receptor; estrogen receptor alpha; estrogen receptor beta; estrogen response element; insulin receptor; IR; phosphatidylinositol 3 kinase; PI3 kinase

Indexed keywords

ESTRADIOL; INSULIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; DNA; GLUCOSE;

ARTICLE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; HORMONE ACTION; HUMAN; HUMAN CELL; INSULIN RESISTANCE; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; BIOSYNTHESIS; CELL CULTURE; DOSE RESPONSE; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; OXIDATION REDUCTION REACTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL SURVIVAL; CELLS, CULTURED; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; INSULIN RESISTANCE; OXIDATION-REDUCTION; PROMOTER REGIONS (GENETICS); RECEPTOR, INSULIN; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 8444229299     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.05.012     Document Type: Article

References (70)

1. Nilsson S., Mäkelä S., Treuter E., Tujague M., Thomsen J., Andersson G., et al. Mechanisms of estrogen action. Physiol. Rev. 81:2001;1535-1565
2. Weihua Z., Andersson S., Cheng G., Simpson E.R., Warner M., Gustafsson J.A. Update on estrogen signaling. FEBS Lett. 546:2003;17-24
3. Livingston C., Collison M. Sex steroids and insulin resistance. Clin. Sci. 102:2002;151-166
4. Tang-Feng T., Francke V. Gene for human insulin receptor localization to site on chromosome 19 involved in pre-β-cell leukemia. Nature. 228:1985;728-730
5. Withers D.J., White M. Perspective: the insulin signaling system - a common link in the pathogenesis of type 2 diabetes. Endocrinology. 141:2000;1917-1921
6. Johnston A.M., Pirola L., Van Obberghen E. Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signalling. FEBS Lett. 546:2003;32-36
7. Nuclear Receptors Nomenclature Committee. A unified nomenclature system for the nuclear receptor superfamily. Cell 1999;97:161-3.
8. Green S., Walter P., Kumar V., Krust A., Bornert J.M., Argos P., et al. Human oestrogen receptor cDNA: sequence expression and homology to v-erb-A. Nature. 320:1986;134-139
9. Enmark E., Pelto-Huikko M., Grandien K., Lagercrantz S., Lagercrantz J., Fried G., et al. Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern. J. Clin. Endocrinol. Metab. 82:1997;4258-4265
10. Pettersson K., Gustafsson J.A. Role of estrogen receptor beta in estrogen action. Annu. Rev. Physiol. 63:2001;165-192
11. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesno K., et al. The nuclear receptor superfamily: the second decade. Cell. 83:1995;835-839
12. Hall J.M., Couse J.F., Korach K.S. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 276:2001;36869-36872
13. McDonnell D.P., Norris J.D. Connections and regulation of the human estrogen receptor. Science. 296:2002;1642-1644
14. Leal M.A., Cabañas C., Rius C., Aller P., Calle C. Modulation by dexamethasone of insulin binding and insulin receptor mRNA levels in U-937 human promonocytic cells. Biochimie. 74:1992;545-549
15. Leal M.A., Aller P., Calle C. Effect of dexamethasone on insulin receptor mRNA levels RNA stability and isotype RNA. J. Endocrinol. Invest. 19:1996;530-534
16. Calle C., Campion J., Garcia-Arencibia M., Maestro B., Davila N. Transcriptional inhibition of the human insulin receptor gene by aldosterone. J Steroid Biochem. Mol. Biol. 84:2003;543-553
17. Campion J., Maestro B., Mata F., Davila N., Carranza C., Calle C. Inhibition by aldosterone of insulin receptor mRNA levels and insulin binding in U-937 human promonocytic cells. J. Steroid Biochem. Mol. Biol. 70:1999;211-218
18. Campion J., Maestro B., Molero S., Davila N., Carranza M.C., Calle C. Aldosterone impairs responsiveness in U-937 human promonocytic cells via the downregulation of its own receptor. Cell Biochem. Funct. 20:2002;237-245
19. Papa V., Reese C.C., Brunetti A., Vigneri R., Siiteri P.K., Goldfine I.D. Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells. Cancer Res. 50:1990;7858-7862
20. Sesti G., Marini M.A., Briata P., Tullio A.N., Montemurro A., Borboni P., et al. Androgens increase insulin receptor mRNA levels, insulin binding, and insulin responsiveness in HEp-2 larynx carcinoma cells. Mol. Cell Endocrinol. 86:1992;111-118
21. Thomopoulos P., Testa U., Gourdin M.F., Hervy C., Titeux M., Vainchenker W. Inhibition of insulin receptor binding by phorbol esters. Eur. J. Biochem. 129:1982;389-393
22. Abita J.P., Gauville C., Balitrand N., Gespach C., Canivet J. Binding of 125I-insulin to the human histiocytic lymphoma cell line U-937: effect of differentiation with retinoic acid. Leuk. Res. 8:1984;213-221
23. Robert A., Grunberger G., Carpenter J.L., Dayer J.M., Orci L., Gorden P. The insulin receptor of a human monocyte-like cell line: characterization and function. Endocrinology. 114:1984;247-253
24. Vegeto E., Pollio G., Pellicciari C., Maggi A. Estrogen and progesterone induction of survival of monoblastoid cells undergoing TNF-alpha-induced apoptosis. FASEB. J. 13:1999;793-803
25. Mor G., Sapi E., Abrahams V.M., Rutherford T., Song J., Hao X.Y., et al. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J. Immunol. 170:2003;114-122
26. 3 on insulin binding, insulin receptor mRNA levels, and isotype RNA pattern in U-937 human promonocytic cells. Exp. Cell Res. 217:1995;189-194
27. 3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr. J. 47:2000;383-391
28. 3. Cell Biochem. Funct. 20:2002;227-232
29. Maestro B., Davila N., Carranza M.C., Calle C. Identification of a Vitamin D response element in the human insulin receptor gene promoter. J. Steroid Biochem. Mol. Biol. 84:2003;223-230
30. Mas A., Campion J., Aller P., Calle C. Epinephrine-induced reduction in insulin receptor mRNA level and stability in U-937 human promonocytic cells. Horm. Metab. Res. 30:1998;118-122
31. Sundström C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer. 17:1976;565-577
32. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159
33. Bonnerot C., Rocancourt P., Briand G., Grimber J.F., Nicolas A. β-Galactosidase hybrid protein targeted to the nuclei as a marker for developmental studies. Proc. Natl. Acad Sci. 84:1987;6795-6799
34. Hatada E.N., McLain D.A., Potter E., Ullrich A., Olefsky J.M. Effects of growth and insulin treatment on the levels of insulin receptors and their mRNA in HEPG2 cells. J. Biol. Chem. 264:1989;6741-6747
35. Kashiwagi A., Verso M.A., Andrews J., Vasquez B., Reaven G., Foley J.E. In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus. J. Clin. Invest. 72:1983;1246-1254
36. MacLennan I.C.M., Golstein P. Requirement for hexose, unrelated to energy provision, in T-cell-mediated cytolysis at the lethal hit stage. J. Exp. Med. 147:1978;1551-1567
37. Kanai F., Ito K., Todaka M., Hayashi H., Kamohara S., Ishii K., et al. Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI3-kinase. Biochem. Biophys. Res. Commun. 195:1993;762-768
38. Tewari D.S., Cook D.M., Taub R. Characterization of the promoter region and 3′ end of the human insulin receptor gene. J. Biol. Chem. 264:1989;16238-16245
39. Bertoli A., De Pirro R., Fusco A., Greco A.V., Magnatta R., Lauro R. Differences in insulin receptors between men and menstruating women and influence of sex hormones on insulin binding during the menstrual cycle. J. Clin. Endocrinol Metab. 50:1980;246-250
40. Suenaga R., Mitamura K., Evans M.J., Abdou N.I. Binding affinity and quantity of estrogen receptor in peripheral blood monocytes of patients with systemic lupus erythematosus. Lupus. 5:1996;227-231
41. Alexander D.C., Miller W.L. Regulation of ovine follicle-stimulating hormone β-chain mRNA by 17β-estradiol in vivo and in vitro. J. Biol. Chem. 5:1982;2282-2286
42. Phillips C.L., Lin L.W., Wu J.C., Guzman K., Milsted A., Miller W.L. 17 beta-estradiol and progesterone inhibit transcription of the genes encoding the subunits of ovine follicle-stimulating hormone. Mol. Endocrinol. 2:1988;641-649
43. Girasole G., Jilka R.L., Passeri G., Boswell S., Boder G., Williams D.C., et al. 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblast in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J. Clin. Invest. 89:1992;883-891
44. Korc-Grodzicki B., Ren N., Hilf R. Effects of estradiol on the expression and production of IGFBP-2 by R3230AC mammary tumor cells. Oncol. Res. 8:1996;473-483
45. Stone D.J., Song Y., Anderson C.P., Krohn K.K., Finch C.E., Rozovsky I. Bidirectional transcription regulation of glial fibrillary acidic protein by estradiol in vivo and in vitro. Endocrinology. 139:1998;3202-3209
46. Miller C.D., Miller W.L. Transcriptional repression of the ovine follicle-stimulating hormone-β gene by 17β-estradiol. Endocrinology. 137:1996;3437-3446
47. Kurebayashi S., Miyashita Y., Hirose T., Kasayama S., Akira S., Kishimoto T. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor. J. Steroid Biochem. Mol. Biol. 60:1997;11-17
48. Keri R.A., Andersen B., Kennedy G.C., Hamernik D.L., Clay C.M., Brace A.D., et al. Estradiol inhibits transcription of the human glycoprotein hormone β-subunit gene despite the absence of a high affinity binding site for estrogen receptor. Mol. Endocrinol. 5:1991;725-733
49. Kepa J.K., Neely C.I., Jacobsen B.M., Bruder J.M., McDonnell D.P., Leslie K.K., et al. Estrogen receptor mediated repression of a rat gonadotropin releasing hormone (GnRH) promoter activity in hypothalamic cells. Endocr. Rev. 2:1994;1-10
50. Klinge C.M. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res. 29:2001;2905-2919
51. Hilf R., Hissin P.J., Shafie S.M. Regulatory interrelationships for insulin and estrogen action in mammary tumors. Cancer Res. 38:1978;4076-4085
52. Hilf R. The actions of insulin as a hormonal factor in breast cancer. In: Pike MC, Siiteri PK, Welsch CW, editors. Hormones and breast cancer. New York: Cold Spring Harbor Laboratory; 1981. p. 317.
53. Hilf R., Crofton D.H. Effects of estradiol on insulin receptor distribution in primary cultures of R3230AC mammary adenocarcinoma of the rat. Endocrinology. 116:1985;154-163
54. Beck-Nielsen H., Kühl C., Pedersen O., Bjerre-Christensen C., Nielsen T.T., Klebe J.G. Decreased insulin binding to monocytes from normal pregnant women. J. Clin. Endocrinol. Metab. 49:1979;810-814
55. Tsibris J.C.M., Raynor L.O., Buhi W.C., Buggie J., Spellacy W.N. Insulin receptors in circulating erythrocytes and monocytes from women on oral contraceptives or pregnant women near term. J. Clin. Endocrinol. Metab. 51:1980;711-717
56. De Pirro R., Forte F., Liberti M., Gallkucci M., Monaco F., Lauro R. Effect of cyproterone acetate and conjugated estrogens on the human insulin receptor. Drug Dev. Res. 2:1982;95-99
57. Pagano G., Cassader M., Massobrio M., Bozzo C., Trossarelli G.F., Menato G., et al. Insulin binding to human adipocytes during late pregnancy in healthy obese and diabetic state. Horm. Metab. Res. 12:1980;177-181
58. Hjollund E., Pedersen O., Espersen T., Klebe J.G. Impaired insulin receptor binding and postbinding defects of adipocytes from normal and diabetic pregnant women. Diabetes. 35:1986;598-603
59. Kawashima K., Yamakawa K., Takahashi W., Takizawa S., Yin P., Sugiyama N., et al. The estrogen-occupied estrogen receptor functions as a negative regulator to inhibit cell proliferation induced by insulin/IGF-1: a cell context-specific antimitogenic action of estradiol on rat lactotrophs in culture. Endocrinology. 143:2002;2750-2758
60. Morey A.K., Pedram A., Razandi M., Prins B.A., Hu R.M., Biesiada E., et al. Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology. 138:1997;3330-3339
61. Collison M., Campbell I.W., Salt I.P., Dominiczak A.F., Lyall H., Gould G.W., Connell J.M.C. Sex hormones induce insulin resistance in 3T3-L1 adipocytes by reducing celular content of IRS proteins. Diabetologia. 43:2000;1374-1380
62. Caro C., Colby-Germinario S., Brenner B., Oliveira M., Wainberg M.A., Germinario R.J. Sugar transport and glut transporter expression in a variety of human immunodeficiency virus-1 (HIV-1) chronically infected target cell lines. Int. J. Biochem. Cell Biol. 30:1998;1031-1038
63. Ahmed N., Berridge M.V. N-glycosylation of glucose transporter-1 (Glut-1) is associated with increased transporter affinity for glucose in human leukemic cells. Leuk. Res. 23:1999;395-401
64. Calderhead D.M., Kitagama K., Lienhard G.E., Gould G.W. Translocation of the brain-type glucose transporter largely accounts for insulin stimulation of glucose transport in BC3H-1 myocytes. Biochem. J. 269:1990;597-601
65. Usui I., Takata Y., Imamura T., Morioka H., Sasaoka T., Sawa T., et al. Fatty acid induced insulin resistance in rat-1 fibroblasts overexpressing human insulin receptors: impaired insulin-stimulated mitogen-activated protein kinase activity. Diabetologia. 40:1997;894-901
66. Afzal I., Cunningham P., Naftalin R.J. Interactions of ATP, oestradiol, genistein and the anti-oestrogens, faslodex (ICI 182780) and tamoxifen, with the human erythrocyte glucose transporter, GLUT1. Biochem. J. 365:2002;707-719
67. Clarke J.F., Young P.W., Yonezawa K., Kasuga M., Holman G.D. Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem. J. 300:1994;631-635
68. Yamanouchi T., Tsushima T., Akanuma Y., Kasuga M., Mizoguchi H., Takaku F. Characteristics of insulin action in human myelogenous leukemia cell line K-562. Diabetes. 34:1985;347-352
69. Simoncini T., Hafezi-Moghadam A., Brazil D.P., Ley K., Chin W.W., Llao J.K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature. 407:2000;538-541
70. Simoncini T., Genazzani A.R. Non-genomic actions of sex steroid hormones. Eur. J. Endocrinol. 148:2003;281-292